CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 11 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -48.3% | 21,786 | -11.1% | 0.00% | – |
| Q2 2023 | $29 | -99.3% | 24,497 | +624.1% | 0.00% | – |
| Q3 2022 | $4,000 | -33.3% | 3,383 | -48.7% | 0.00% | – |
| Q2 2022 | $6,000 | -83.3% | 6,595 | -67.2% | 0.00% | – |
| Q1 2022 | $36,000 | -91.5% | 20,112 | -92.7% | 0.00% | – |
| Q4 2021 | $424,000 | +351.1% | 275,662 | +494.0% | 0.00% | – |
| Q3 2021 | $94,000 | -48.6% | 46,406 | -11.7% | 0.00% | – |
| Q2 2021 | $183,000 | +976.5% | 52,575 | +462.6% | 0.00% | – |
| Q1 2021 | $17,000 | – | 9,345 | +84854.5% | 0.00% | – |
| Q4 2019 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 135,508 | $472,000 | 0.15% |
| Wealth Advisory Solutions, LLC | 156,850 | $546,000 | 0.13% |
| Horst & Graben Wealth Management LLC | 75,722 | $264,000 | 0.07% |
| Miller Investment Management, LP | 50,000 | $174,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 44,655 | $155,000 | 0.02% |
| Triton Wealth Management, PLLC | 13,100 | $24,000 | 0.01% |
| Renaissance Technologies | 1,898,351 | $6,606,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 19,000 | $66,000 | 0.01% |
| Virtu Financial LLC | 19,713 | $69,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 47,265 | $164,000 | 0.01% |